Skip to main content

Browse


Sero-profiling identifies ibrutinib as a treatment option for young adults with B-cell acute lymphoblastic leukaemia (2019)
Journal Article
Guinn, B., Jordaens, S., Cooksey, L., Coutinho, M., Van Tendeloo, V., Mills, K., & Orchard, K. (in press). Sero-profiling identifies ibrutinib as a treatment option for young adults with B-cell acute lymphoblastic leukaemia. British journal of haematology,

Acute lymphoblastic leukaemia (ALL) is a haematological malignancy that is characterized by the uncontrolled proliferation of immature lymphocytes. 80 % of cases occur in children where ALL is well understood and treated. However it has a devastating... Read More about Sero-profiling identifies ibrutinib as a treatment option for young adults with B-cell acute lymphoblastic leukaemia.